Bioinvent International
IPOUnleashing Immunity to Fight Cancer
- Headquarters
- Lund
- Business Model
- B2B
- Website
- bioinvent.com
About
BioInvent International is a Swedish clinical-stage biotechnology company that discovers and develops novel antibody-based therapeutics for cancer, using its proprietary F.I.R.S.T™ screening platform and n-CoDeR® antibody library. The company has ongoing collaborations with global pharmaceutical partners including CASI, Merck, Daiichi, and Mitsubishi Tanabe, and also provides contract antibody manufacturing services through BioInvent Manufacturing, active since 1988.
Summary
Bioinvent International is a Biotech company based in Lund, Sweden. Investors include Pfizer Ventures and HBM Healthcare Investments.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2022
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.